Volume 8; Issue 2

Nature Reviews Drug Discovery

Volume 8; Issue 2
2

Knocking down barriers: advances in siRNA delivery

Year:
2009
Language:
english
File:
PDF, 459 KB
english, 2009
3

Systemic lupus erythematosus

Year:
2009
Language:
english
File:
PDF, 232 KB
english, 2009
5

Chloride channels as drug targets

Year:
2008
Language:
english
File:
PDF, 908 KB
english, 2008
6

Lead discovery: Tailoring nuclear receptor activation

Year:
2009
Language:
english
File:
PDF, 155 KB
english, 2009
7

Cancer: Identifying drug–genotype interactions

Year:
2009
Language:
english
File:
PDF, 151 KB
english, 2009
8

Stem cells: Modelling genetic diseases with iPS cells

Year:
2009
Language:
english
File:
PDF, 198 KB
english, 2009
9

Cardiovascular disease: Silencing microRNA rescues the heart

Year:
2009
Language:
english
File:
PDF, 179 KB
english, 2009
10

Lung disease: Antioxidant protection against cigarette smoke

Year:
2009
Language:
english
File:
PDF, 134 KB
english, 2009
11

In Brief

Year:
2009
Language:
english
File:
PDF, 212 KB
english, 2009
12

2008 FDA drug approvals

Year:
2009
Language:
english
File:
PDF, 371 KB
english, 2009
13

News in brief

Year:
2009
Language:
english
File:
PDF, 306 KB
english, 2009
14

Patent watch

Year:
2009
Language:
english
File:
PDF, 239 KB
english, 2009
15

Mark McClellan

Year:
2009
Language:
english
File:
PDF, 124 KB
english, 2009
16

In this issue

Year:
2009
Language:
english
File:
PDF, 240 KB
english, 2009
17

Financing R&D for neglected diseases

Year:
2009
Language:
english
File:
PDF, 96 KB
english, 2009
18

Plerixafor

Year:
2009
Language:
english
File:
PDF, 239 KB
english, 2009
19

Systems biology

Year:
2009
Language:
english
File:
PDF, 166 KB
english, 2009
20

Trial watch: Phase III promise for oral multiple sclerosis therapy

Year:
2009
Language:
english
File:
PDF, 115 KB
english, 2009
21

Deal watch: Bristol–Myers Squibb and Exelixis collaborate on kinase inhibitors

Year:
2009
Language:
english
File:
PDF, 118 KB
english, 2009
22

Regulatory watch: FDA issues guidance for cardiovascular risk assessment of novel antidiabetic agents

Year:
2009
Language:
english
File:
PDF, 183 KB
english, 2009